ANNALS OF THORACIC SURGERY, published by Elsevier Science Inc, is a premier journal that has been serving the fields of cardiology, pulmonary medicine, and surgery since its inception in 1965. With an esteemed Q1 ranking in both Cardiology and Cardiovascular Medicine, as well as in Pulmonary and Respiratory Medicine for 2023, this journal is recognized for its rigorous peer-reviewed articles that contribute significantly to advancing surgical practices and outcomes. The journal boasts impressive Scopus rankings, placing it in the 93rd percentile for Surgery and ensuring it remains a key resource for professionals, researchers, and students. While primarily a subscription-based publication, it provides invaluable insights and original research that drive innovation and improve patient care. For those involved in thoracic surgery, this journal is indispensable, offering a platform for critical developments and collaborative discourse in the field.

Cirugia Cardiovascular is a distinguished open-access journal published by Elsevier, dedicated to advancing the field of cardiovascular surgery and medicine. Established in Spain, this journal serves as a vital platform for disseminating innovative research and clinical insights in the realms of cardiology and surgical practices. With its ISSN 1134-0096 and E-ISSN 1134-0096, Cirugia Cardiovascular has been making impactful contributions to the medical community since becoming an open-access publication in 2005, thus ensuring unrestricted access to critical knowledge. In the most recent evaluation, it was positioned in the Q4 category in both Cardiology and Cardiovascular Medicine and Surgery as of 2023, reflecting its ongoing commitment to improving its scholarly impact. Despite its current ranking within the Scopus database, which highlights its value at percentile ranks of 19th in Surgery and 12th in Cardiology and Cardiovascular Medicine, Cirugia Cardiovascular continues to embrace growth and innovation. The journal aims to unite researchers, clinicians, and students, fostering a collaborative environment to elevate cardiovascular healthcare practices. With a converged year range from 2012 to 2024, it optimally addresses contemporary challenges and advancements in cardiovascular surgical techniques and outcomes.

Arquivos Brasileiros de Cardiologia is a leading open-access journal dedicated to advancing the field of cardiology and cardiovascular medicine. Established in 1950 and published by the ARQUIVOS BRASILEIROS CARDIOLOGIA, this Brazilian journal plays a crucial role in disseminating high-quality research that addresses both emerging and established topics in cardiovascular science. With an impressive history and a commitment to open access since 1997, it provides researchers, healthcare professionals, and students with free and readily available content that significantly contributes to the understanding and management of cardiovascular diseases. The journal is indexed in Scopus and holds a Q3 ranking in the category of Cardiology and Cardiovascular Medicine, demonstrating its relevance and participation within the global research community. Researchers can submit their work and access a wealth of information that spans a variety of subfields, reflecting the journal’s dedication to fostering innovation and collaboration within cardiology. With a mailing address at Avenida Marechal Câmara, 160-330 Centro, Rio de Janeiro, RJ 20,020-907, Brazil, the journal continues to serve as a vital platform for scholarly communication and knowledge exchange in the cardiovascular realm.

ACTA CARDIOLOGICA is a distinguished journal published by TAYLOR & FRANCIS LTD, focusing on the dynamic fields of Cardiology and Cardiovascular Medicine. Established in 1946, the journal has maintained a significant presence in the academic community, providing a platform for cutting-edge research and clinical studies that aim to address challenges in cardiovascular health. With its Q3 rating in both Cardiology and General Medicine categories, it showcases a robust compilation of articles that reflect the evolving landscape of cardiac care. Although ACTA CARDIOLOGICA is not an Open Access journal, it continues to serve a vital role for researchers, professionals, and students dedicated to advancing knowledge in cardiovascular health. This journal, with an ISSN of 0001-5385 and E-ISSN of 1784-973X, is a critical resource for those looking to stay updated on the latest developments and practices in the specialization, contributing significantly to the field until 2024 and beyond.

The Journal of Echocardiography, published by SPRINGER JAPAN KK, is a leading periodical dedicated to advancing the field of echocardiography and cardiac imaging. With an ISSN of 1349-0222 and an E-ISSN of 1880-344X, this journal serves as a vital resource for researchers, clinicians, and students alike, providing a platform for the dissemination of innovative research, case studies, and reviews focused on the latest echocardiographic techniques and applications. Operating under a prestigious publisher with a noteworthy reputation in the academic community, the journal features contributions that significantly impact the current understanding of cardiac health, making it essential reading for those in the fields of medicine, radiology, and imaging. As recognized in the 2023 Category Quartiles, it holds a solid Q3 ranking within the Radiology, Nuclear Medicine and Imaging category, further highlighting its relevance within the field, where it ranks #170 out of 333 according to Scopus. With coverage spanning from 2003 to 2024, the Journal of Echocardiography is committed to fostering an inclusive and comprehensive dialogue on the developments that shape modern echocardiographic practice.

Research in Cardiovascular Medicine is a renowned open-access journal published by Wolters Kluwer Medknow Publications, dedicated to advancing knowledge in the swiftly evolving field of cardiovascular health. With an ISSN of 2251-9572 and E-ISSN of 2251-9580, this journal serves as a vital platform for researchers and professionals to share their findings, explore innovative treatments, and discuss current trends in cardiovascular care. Since transitioning to open access in 2013, it has democratized access to high-quality research, ensuring that vital information reaches healthcare practitioners and academia alike. The journal’s commitment to rigorous peer review and its emphasis on cutting-edge research contribute significantly to improving patient outcomes and addressing the global burden of cardiovascular diseases. By publishing original articles, review papers, and clinical studies, Research in Cardiovascular Medicine plays a crucial role in shaping the future of cardiovascular research and education, appealing to a wide audience of researchers, professionals, and students striving to make meaningful contributions to this critical field.

Kardiologia Polska, the esteemed journal of the Polish Cardiac Society, has established itself as a vital resource in the field of cardiology and cardiovascular medicine since its inception in 1954. With an ISSN of 0022-9032 and an E-ISSN of 1897-4279, this journal serves as a platform for groundbreaking research and scholarly articles that contribute to the advancement of heart health. Although currently not an open access journal, it remains an essential reference for practitioners and researchers seeking to stay abreast of the latest developments in cardiovascular science. The journal reflects its scholarly depth through a Category Quartile of Q3 and a commendable Scopus ranking at the 48th percentile in its field. Published primarily in Poland, it caters to a global audience eager to explore comprehensive studies spanning clinical cardiology, innovative therapeutic approaches, and emerging cardiovascular trends. Join a thriving academic community by engaging with the invaluable insights and research contributions found within the pages of Kardiologia Polska.

Congenital Heart Disease, published by TECH SCIENCE PRESS, is a pivotal academic journal focusing on the complexities of congenital heart conditions. With an ISSN of 1747-079X and an E-ISSN of 1747-0803, this journal serves as a crucial platform for researchers and healthcare professionals engaged in cardiology, pediatrics, and related fields. Established in 2006 and continuing through to 2024, it aims to disseminate insightful research findings and reviews that advance the understanding of congenital heart diseases and their management. The journal currently holds a Q4 classification in cardiology and cardiovascular medicine, with rankings in various medical categories highlighting its dedication to emerging research. Although it does not offer open access, its contributions are vital for professionals seeking to explore innovative strategies and collaborative solutions in congenital heart disease management. As it continues to navigate the evolving landscape of pediatric cardiac health, Congenital Heart Disease is committed to fostering a community of knowledge that impacts both clinical practices and academic inquiry.

Heart Rhythm O2, published by Elsevier and indexed under ISSN 2666-5018, is a premier Open Access journal that has established itself as a vital platform for the dissemination of innovative research in Cardiology and Cardiovascular Medicine. Since its inception in 2020, this journal has rapidly gained recognition, achieving a distinguished Q1 ranking in its field as of 2023, underscoring its commitment to excellence and quality. Operating from its base in the Netherlands, Heart Rhythm O2 aims to bridge the gap between clinical practice and emerging scientific findings, fostering collaboration among researchers, healthcare professionals, and students globally. With a focus on high-impact original research, review articles, and clinical studies, the journal is dedicated to advancing our understanding of cardiac rhythm management and cardiovascular health. With open access options, it ensures that vital knowledge is freely available, facilitating the ongoing education and engagement of the medical community worldwide.

Revista Portuguesa de Cardiologia, published by Elsevier España SLU, stands as a pivotal resource in the realm of Cardiology and Cardiovascular Medicine. With its origins tracing back to 1970, this journal has cultivated a robust academic presence, achieving a 2023 Q3 ranking in its category, and currently holding a position of #220 out of 387 on the Scopus rankings, placing it within the 43rd percentile of its field. This open access journal, available since 2011, aims to disseminate high-quality research and insights relevant to contemporary cardiovascular issues. Its commitment to accessibility and knowledge exchange enhances its importance for clinicians, researchers, and students alike, fostering a more informed community in the fight against cardiovascular diseases. Operating from its base in Barcelona, Spain, the journal welcomes contributions that further the understanding and treatment of heart conditions, contributing significantly to the advancement of cardiovascular health.